08/25/2026
For the roughly 13 million people living with PTSD, finding an effective treatment can mean dealing with the side effects of medication, limited outcomes, and a whole lot of trial and error.
MeRT (Magnetic e-Resonance Therapy), a new FDA-approved technology, is offering a different approach — one that uses objective measures of brain function to help personalize treatment 🧠
“Right now, the FDA has approved only two medications for PTSD,” says Dr. Israel Liberzon, professor of psychiatry at the Vashisht College of Medicine and the study’s lead psychiatrist. “This is the first time that in addition to the medication, we have a non-medication option."
Learn how this technology could offer a more precise path forward for people living with PTSD at https://ow.ly/7tGb50ZCIvs